Table 3.
Univariate and multivariable analysis of OS in relation to baseline variables in the TOTAL and clean group
| Clinical covariates | Total group univariate models HR (95% CI) | p value | Total group multivariable model HR (95% CI) | p value | Clean group univariate models HR (95% CI) | p value | Clean group multivariable models HR (95%) | p value |
|---|---|---|---|---|---|---|---|---|
| Age | 1.007 (0.992–1.023) | 0.371 | 1.008 (0.990–1.027) | 0.369 | ||||
| BMI | 0.948 (0.918–0.979) | 0.001 | 0.952 (0.917–0.990) | 0.012 | ||||
| Gleason score | 0.928 (0.818–1.053) | 0.246 | 0.945 (0.818–1.092) | 0.445 | ||||
| ECOG performance status | 1.534 (1.325–1.775) | < 0.001 | 1.486 (1.282–1.723) | < 0.001 | 1.398 (1.166–1.676) | < 0.001 | 1.345 (1.121–1.615) | 0.001 |
| No. of previous systemic treatments | 1.227 (1.098–1.371) | < 0.001 | 1.212 (1.058–1.389) | 0.005 | ||||
| Baseline Hb | 0.722 (0.663–0.787) | < 0.001 | 0.729 (0.669–0.795) | < 0.001 | 0.709 (0.636–0.787) | < 0.001 | 0.717 (0.643–0.799) | < 0.001 |
| Baseline PSA | 1.001 (1.001–1.001) | < 0.001 | 1.001 (1.001–1.001) | < 0.001 | ||||
| Baseline tALP | 1.001 (1.001–1.002) | < 0.001 | 1.002 (1.001–1.002) | < 0.001 |